“Republican lawmakers on Sunday successfully stripped a $35 price cap on the cost of insulin for many patients from the ambitious legislative package Democrats are moving through Congress this weekend, invoking arcane Senate rules to jettison the measure,” the Washington Post reports.
“The insulin cap is a long-running ambition of Democrats, who want it to apply to patients on Medicare and private insurance. Republicans left untouched the portion that applies to Medicare patients but stripped the insulin cap for other patients.”
New York Times: “Seven Republicans voted with Democrats to keep the cap for private insurers in the bill, but a 57-to-43 margin is three votes short of overcoming the objection.”
Nearly 8 million Americans rely on insulin each month to manage diabetes.
